Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Graham Goldsmith | M | 63 | 12 years | |
| Ronnie Fink | M | - | 19 years | |
| Simon Lusted | M | - | 14 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregory Denis O’Reilly | M | - | 4 years | |
| Neil Chatfield | M | 70 | 13 years | |
| Paul Bassat | M | 55 | 14 years | |
| Andrew John MacDonald | M | 64 |
Cytopia Ltd.
 Cytopia Ltd. Pharmaceuticals: MajorHealth Technology Cytopia Ltd. primarily engages in discovers and develops drugs to treat cancer and other diseases. The company commenced operations in 1997 in Melbourne, Australia, and has developed kinase enzyme biology and integrated a robust structural biology program with medicinal chemistry & drug development. The company conducts its research and drug development through subsidiaries based in Australia and the USA and also develops small molecule compounds with therapeutic profile for the treatment of cancer. The company has concluded two phase I safety and tolerability studies for its lead anticancer vascular disrupting agent, CYT997. It was founded on August 11, 1997 and is located in Melbourne, VI. | 6 years |
| Moana Weir | F | - | 5 years | |
| Roderick Lyle | M | 69 |
Cytopia Ltd.
Cytopia Ltd. Pharmaceuticals: MajorHealth Technology Cytopia Ltd. primarily engages in discovers and develops drugs to treat cancer and other diseases. The company commenced operations in 1997 in Melbourne, Australia, and has developed kinase enzyme biology and integrated a robust structural biology program with medicinal chemistry & drug development. The company conducts its research and drug development through subsidiaries based in Australia and the USA and also develops small molecule compounds with therapeutic profile for the treatment of cancer. The company has concluded two phase I safety and tolerability studies for its lead anticancer vascular disrupting agent, CYT997. It was founded on August 11, 1997 and is located in Melbourne, VI. | 6 years |
| Natalie Mactier | F | - | - | |
| Denise Irene Bradley | F | 82 | 10 years | |
| Eddie Collis | M | - | - | |
| Robert Thomas | M | 79 | 12 years | |
| Colin Bruce Carter | M | 80 | 13 years | |
| Joel Reynolds | M | 47 | 7 years | |
| David Gibbons | M | - | 2 years | |
| Michael John Ilczynski | M | - | 13 years | |
| Dan Krasnostein | M | - | 3 years | |
| Katie May | F | 56 | 6 years | |
| Lior Harel | M | - | 6 years | |
| Christopher John Anderson | M | 78 | 5 years | |
| Ian J. McAuliffe | M | - | 10 years | |
| Gregg Smith | M | - |
Cytopia Ltd.
Cytopia Ltd. Pharmaceuticals: MajorHealth Technology Cytopia Ltd. primarily engages in discovers and develops drugs to treat cancer and other diseases. The company commenced operations in 1997 in Melbourne, Australia, and has developed kinase enzyme biology and integrated a robust structural biology program with medicinal chemistry & drug development. The company conducts its research and drug development through subsidiaries based in Australia and the USA and also develops small molecule compounds with therapeutic profile for the treatment of cancer. The company has concluded two phase I safety and tolerability studies for its lead anticancer vascular disrupting agent, CYT997. It was founded on August 11, 1997 and is located in Melbourne, VI. | 6 years |
| B. Highfield | M | - | - | |
| James Packer | M | 56 | 6 years | |
| Carey M. T. Eaton | M | - | 4 years | |
| Guy Jalland | M | - | - | |
| John Ludeke | M | 74 | 1 years | |
| Terence Mallon | M | 81 | 1 years | |
| William A. Bartee | M | - | 2 years | |
| Bernard B. McInerney | M | 65 | 2 years | |
| Tam K. Vu | M | - | 2 years | |
| John Alexander | M | 73 | 6 years | |
| Fiona Le Brocq | F | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 34 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Watson
- Personal Network
